e-Drug3D 976 |
CAPREOMYCIN DISCONTINUED
|
cas 11003-38-6 |
CLASS ANTIINFECTIVES |
ROUTE (list) INJECTION |
ATC code |
PK parameters Tmax 1.5 HOUR Solubility SOLUBLE IN WATER |
Target TARGET 50S RIBOSOMAL PROTEIN L10 |
DrugCentral Unknown |
Download SDF file | (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide Formula: Calculated chemical properties: MW 668.74 NB_atoms 47 XLogP -8.03 PSA 330.588 NB_HD 19 NB_HA 22 fsp3 0.60 Lipinski(0=no;1=yes) 0 |
FDA NDA 050095 (pdf not found) INN (CAPREOMYCIN SULFATE) CAPASTAT SULFATE (EPIC PHARMA LLC) APPROVAL= AP YEAR= 1971 DISCONTINUED NDA 202634 (pdf not found) INN (CAPREOMYCIN SULFATE) CAPREOMYCIN SULFATE (NORVIUM BIOSCIENCE) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 204796 (pdf not found) INN (CAPREOMYCIN SULFATE) CAPREOMYCIN SULFATE (HISUN PHARM HANGZHOU) APPROVAL= AP YEAR= 2018 DISCONTINUED |
Other links: |